Company Profiles

driven by the PitchBook Platform

ImaginAb

Description

Developer of engineered antibody fragments for diagnostic imaging and radio immunotherapy. The company's clinical product pipeline comprises prostate stem cell antigen for prostate, bladder and pancreatic cancer; J591 prostate-specific membrane antigen for prostate cancer and T-cell co-receptor for cancer, inflammation and transplantation. It also offers companion imaging agents, pre-clinical in vivo validation, clinical studies translation and custom antibody engineering services.

2007

Founded

PRIVATE

Status

11-50

Employees

Series A3

Latest Deal Type

$5.34M

Latest Deal Amount

$38.6M

Total Amount Raised

Description

Developer of engineered antibody fragments for diagnostic imaging and radio immunotherapy. The company's clinical product pipeline comprises prostate stem cell antigen for prostate, bladder and pancreatic cancer; J591 prostate-specific membrane antigen for prostate cancer and T-cell co-receptor for cancer, inflammation and transplantation. It also offers companion imaging agents, pre-clinical in vivo validation, clinical studies translation and custom antibody engineering services.

Website:

www.imaginab.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

423 Hindry Avenue Suite D Inglewood, CA 90301United States +1 (310) 645-1211
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore ImaginAb's full profile, request a free trial.

    ImaginAb Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    ImaginAb Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    ImaginAb Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Cycad GroupVenture CapitalMinority000 0000000 0000
    Mérieux DéveloppementVenture CapitalMinority000 0000000 0000
    Momentum BiosciencesVenture CapitalMinority000 0000000 0000
    Nextech InvestVenture CapitalMinority000 0000000 0000
    Novartis Venture FundCorporate Venture CapitalMinority000 0000000 0000
    Cycad Group Venture Capital
    Mérieux Développement Venture Capital
    Momentum Biosciences Venture Capital
    Nextech Invest Venture Capital
    Novartis Venture Fund Corporate Venture Capital

    ImaginAb Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Martyn CoombsChief Executive Officer
    Jeff QuanChief Financial Officer
    Jennifer KepplerChief Operating Officer
    Anna Wu Ph.DCo-Founder, Board Member & Chief Scientist
    Robert Reiter MDCo-Founder & Chief Medical Advisor
    Martyn Coombs Chief Executive Officer
    Jeff Quan Chief Financial Officer
    Jennifer Keppler Chief Operating Officer
    Anna Wu Ph.D Co-Founder, Board Member & Chief Scientist
    Robert Reiter MD Co-Founder & Chief Medical Advisor

    ImaginAb Board Members (8)

    NameRepresentingRoleSinceContact
    Info
    Abbie Celniker Ph.DSelfDirector000 0000
    Campbell Murray MDNovartis Venture FundManaging Director000 0000
    Isaac Bright MDMérieux DéveloppementPartner000 0000
    Jeffrey BaileySelfDirector000 0000
    Joesph LimberImaginAbChairman000 0000
    Abbie Celniker Ph.D Director Self
    Campbell Murray MD Managing Director Novartis Venture Fund
    Isaac Bright MD Partner Mérieux Développement
    Jeffrey Bailey Director Self
    Joesph Limber Chairman ImaginAb
    Request full access to PitchBook